Last updated: November 20, 2023
Sponsor: Sentara Cardiovascular Research Institute
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lung Cancer
Lung Disease
Non-small Cell Lung Cancer
Treatment
Harmonic ACE23P Scalpel
Electrocautery
Clinical Study ID
NCT00591552
SCRI-001
SCRI-001
Ages 20-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients undergoing resection for stage 1, 2 or 3A lung cancer.
- Patients between the ages of 20-75.
Exclusion
Exclusion Criteria:
- History of Congestive Heart Failure.
- History of renal failure, ie., creatinine greater than 2.2.
- Patients with bulky or matted lymph nodes in stage 3A.
- Current pregnancy.
- Current participation in another study involving an investigational device or drug.
Study Design
Total Participants: 50
Treatment Group(s): 2
Primary Treatment: Harmonic ACE23P Scalpel
Phase:
Study Start date:
December 01, 2007
Estimated Completion Date:
November 30, 2024
Study Description
Connect with a study center
Sentara Norfolk General Hospital/Sentara Heart Hospital
Norfolk, Virginia 23507
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.